SARMs

Andarine (S4) 25 mg Vital Research

Vital Research

60,00

In Stock (100 available)

Andarine (S4) 25 mg Vital Research (25 mg) — Precision-dosed by Vital Research for consistent results, an early-generation SARM developed for treatment of muscle wasting and o…

100 in stock

This product is for laboratory research use only. Not for human consumption.

5+ −10%
10+ −15% Best price
Third-Party Lab Report HPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
HPLC TestedBatch report available
No Labels on BoxPlain brown parcel
Pay the CourierCash on delivery only
Ships TodayOrder before 14:00
€85+ = free shipping
EU warehouse — no customs, no delays
Tracked via DHL / DPD / InPost
Categories: ,

Description

Andarine (S4) 25 mg Vital Research — Precision-dosed for consistent results, an early-generation SARM developed for treatment of muscle wasting and osteoporosis. It provides moderate muscle-building effects with notable fat loss and hardening properties. Andarine is valued for producing a lean, hard, dry physique similar to Winstrol but with SARM-level side effect mitigation. This formulation is dosed at 25 mg per unit.

Key Benefits

  • S-4 SARM — selective androgen receptor activation with partial profile
  • Effective at body-recomposition dosing
  • Distinct visual side-effect (yellow tinge) from ocular-pigment binding
  • Oral once or twice daily
  • Mild HPTA suppression — mini-PCT advisable
  • Each unit dosed at 25 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: 25–50 mg/day split twice daily for 6–8 weeks. Split dosing smooths plasma. Above 50 mg/day the visual side-effect (yellow tinge / night-vision impairment) amplifies.

How It Works

Selective androgen receptor modulator with partial agonism profile. Tissue-selective effect on muscle and bone with minimal prostate/skin impact. Downstream anabolic signal milder than full-potency SARMs (ligandrol, RAD-140).

Pharmacokinetics

Plasma half-life approximately 4 hours — twice-daily dosing required. Oral bioavailability reasonable. Reconstituted oil or powder stable at room temperature.

Potential Side Effects

Signature visual disturbance: yellowing tint to vision, especially in low light. Resolves within 1–2 weeks of discontinuation. Mild HPTA suppression. HDL drops slightly.

Cycle & Stacking Guide

6–8 week cycles, 25–50 mg/day. Mini-PCT (Nolva 20 mg × 3 weeks) after 8-week runs. Often stacked with Ostarine or cardarine for cutting protocols.

Manufacturer Notes

Vital Research focuses on research compounds and support supplements with batch-specific quality control documentation.

Storage & Handling

Store at recommended temperature (15–25°C; peptides and HGH at 2–8°C after reconstitution). Protect from light and moisture. Keep out of reach of children. For research and educational purposes only.

Reviews

There are no reviews yet.

Be the first to review “Andarine (S4) 25 mg Vital Research”

Your email address will not be published. Required fields are marked *

Andarine

Physical & Chemical Properties for Research Purposes
Chemical structure of Andarine (C19H18F3N3O6) for laboratory analysis
2D structural representation · PubChem CID 9824562 ↗
Chemical Identity
# CAS Registry Number 401900-40-1
Σ IUPAC Name (2S)-3-(4-acetamidophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide
F Molecular Formula C19H18F3N3O6
M Molecular Weight 441.36 g/mol
SMILES CC(=O)NC1=CC=C(OC[C@](C)(O)C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)C=C1[N+]([O-])=O
InChIKey LMEWRZSPCQHBOB-MRVPVSSYSA-N
Melting Point 124-128 °C
Solubility Soluble in DMSO, ethanol; poorly soluble in water
Biological Half-life 4-6 hours (oral)
PubChem CID 9824562 ↗
Pharmacological Profile
Anabolic Rating N/A (non-steroidal)
Androgenic Rating N/A (tissue-selective)
Aromatization None
Hepatotoxicity Low
Detection Time 2-3 weeks
Known trade names: Andarine, S-4, GTx-007

Data sourced from published pharmacological literature and authoritative chemical databases (PubChem, DrugBank, ChEBI). Provided for identification and research reference only.